Related Experiment Video
Updated: May 21, 2026
07:59
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Genomic medicine and lung diseases.
David M Center1, David A Schwartz, Julian Solway
1Pulmonary, Allergy, Sleep, and Critical Care Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Summary
Genomic medicine offers new ways to understand and treat lung diseases at the molecular level. Further research is crucial to translate these genomic discoveries into clinical benefits for patients.
Area of Science:
- Pulmonary Medicine
- Genomic Medicine
- Molecular Biology
Background:
- The rapid advancement of genomic data and technology presents opportunities to redefine lung diseases.
- Current research needs to bridge the gap between genomic discoveries and clinical applications for lung diseases.
Purpose of the Study:
- To discuss the potential of integrated genomics and systems approaches in pulmonary medicine.
- To identify promising research opportunities for clinical benefits in lung genomics.
Main Methods:
- Convened a workshop titled "Genomic Medicine and Lung Diseases."
- Sessions covered molecular phenotypes, biomarkers, therapeutics, new technologies, integrative genomics, lung anatomy, data platforms, and research recommendations.
Main Results:
- Identified opportunities to redefine lung diseases at the molecular level.
- Highlighted the need for translating genomic discoveries into clinical applications like early detection and targeted therapies.
- Discussed the potential of integrated genomics and systems approaches to advance pulmonary medicine.
Conclusions:
- Genomic medicine holds significant promise for advancing pulmonary medicine.
- Translating genomic research into clinical practice is essential for improving lung disease diagnosis, treatment, and patient outcomes.
- Further research and novel platforms are needed to realize the full potential of lung genomics.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.